Skip to Content
Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Clorox Posts Bleak Q4 Profits Due to Unrelenting Costs, but Investors Wise to Keep an Eye on Shares

Erin Lash, CFA Sector Director

Analyst Note

| Erin Lash, CFA |

CEO Linda Rendle has endured an onslaught of challenges since taking the helm at Clorox almost a year ago. When she moved into the corner office, Clorox was flying high as consumers gravitated toward its mix of cleaning and disinfecting fare. However, the dissemination of vaccines (particularly in its home market--more than 80% of total sales) combined with a rampant surge in broad-based cost pressures (qualitatively referred to as unprecedented relative to the last few decades) has constrained sales and profits of late. As a result, fiscal 2021 fourth-quarter organic sales plunged 10%, and gross margins eroded a whopping 970 basis points to 37.1% (the lowest we’ve seen). And this has weighed on its share price, now down nearly 20% since the start of calendar 2021 after more than 30% appreciation in 2020.

Read Full Analysis

Company Profile

Business Description

With a history dating back more than 100 years, Clorox now sells a variety of consumer staples products, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm’s portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt’s Bees. Just shy of 85% of Clorox’s sales stem from its home turf.

1221 Broadway
Oakland, CA, 94612-1888
T +1 510 271-7000
Sector Consumer Defensive
Industry Household & Personal Products
Most Recent Earnings Jun 30, 2021
Fiscal Year End Jun 30, 2022
Stock Type Slow Growth
Employees 9,000